Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

被引：0
|
作者：
Jaime Gómez-Millán
Maria Dolores Toledo
Yolanda Lupiañez
Antonio Rueda
Jose Manuel Trigo
Antonio Sachetti
Jose Antonio Medina
机构：
[1] Hospital Clinico Universitario Virgen de la Victoria,Radiation Oncology Department
[2] Hospital Costa del Sol Marbella,Medical Oncology Department
[3] Hospital Clinico Universitario Virgen de la Victoria,Medical Oncology Department
[4] Radiation Oncology Department Centro radio-oncológico andaluz (CROASA),undefined
来源：
Clinical and Translational Oncology | 2013年 / 15卷
关键词：
Head and neck cancer; Late toxicity; Accelerated radiation; Concomitant boost radiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 326
页数：5
相关论文
共 50 条
  • [21] The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?
    Lindsay Carlsson
    Scott V. Bratman
    Lillian L. Siu
    Anna Spreafico
    Current Treatment Options in Oncology, 2017, 18
  • [22] Feasibility and Efficacy of Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined with Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer
    Pehlivan, Berrin
    Luthi, Francois
    Matzinger, Oscar
    Betz, Michael
    Dragusanu, Daniela
    Bulling, Shelley
    Bron, Luc
    Pasche, Philippe
    Seelentag, Walter
    Mirimanoff, Rene O.
    Zouhair, Abderrahim
    Ozsahin, Mahmut
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (05) : 1337 - 1343
  • [23] Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced nasopharyngeal carcinoma
    Isobe K.
    Uno T.
    Aruga T.
    Kawakami H.
    Ueno N.
    Hanazawa T.
    Okamoto Y.
    Ito H.
    International Journal of Clinical Oncology, 2005, 10 (3) : 201 - 203
  • [24] Feasibility and Efficacy of Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined with Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer
    Berrin Pehlivan
    Francois Luthi
    Oscar Matzinger
    Michael Betz
    Daniela Dragusanu
    Shelley Bulling
    Luc Bron
    Philippe Pasche
    Walter Seelentag
    René O. Mirimanoff
    Abderrahim Zouhair
    Mahmut Ozsahin
    Annals of Surgical Oncology, 2009, 16 : 1337 - 1343
  • [25] Gefitinib plus concomitant boost accelerated radiation (AFX-CB) and concurrent weekly cisplatin for locally advanced unresectable squamous cell head and neck carcinomas (SCCHN): A phase II study
    Rueda, A.
    Medina, J. A.
    Mesia, R.
    Galiana, R.
    Vega, M. E.
    Collado, A.
    Cobo, M.
    Contreras, J.
    Margueli, M.
    Alba, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
    Kim, Sangwoo S.
    Liu, Hannah C.
    Mell, Loren K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (03) : 147 - 161
  • [27] Concomitant Weekly Cisplatin and Altered Fractionation Radiotherapy in Locally Advanced Head and Neck Cancer
    Newlin, Heather E.
    Amdur, Robert J.
    Riggs, Charles E.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    CANCER, 2010, 116 (19) : 4533 - 4540
  • [28] Concomitant chemoradiotherapy with weekly Cisplatin and subcutaneous Amifostin in the treatment of advanced head and neck cancer
    Pala, M
    Holeckova, P
    Vitek, P
    Kubes, J
    Vesely, J
    Svobodnik, A
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S308 - S308
  • [29] Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
    Sangwoo S. Kim
    Hannah C. Liu
    Loren K. Mell
    Current Treatment Options in Oncology, 2023, 24 : 147 - 161
  • [30] Concurrent cisplatin and concomitant boost accelerated radiotherapy (CBAR) in advanced head end neck (H&N) cancer
    Gabrovski, R
    Todorov, J
    Tzanev, M
    Dimov, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S173 - S173
12345